Literature DB >> 20827258

Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury.

Jochen Metzger1, Torsten Kirsch, Eric Schiffer, Perihan Ulger, Ebru Mentes, Korbinian Brand, Eva M Weissinger, Marion Haubitz, Harald Mischak, Stefan Herget-Rosenthal.   

Abstract

Early and accurate detection of acute kidney injury (AKI) is needed to prevent the progression to chronic kidney disease and to improve outcome. Here we used capillary electrophoresis-mass spectrometry to identify urinary peptides predictive of AKI in a training set of 87 urine samples longitudinally collected from patients in an intensive care unit. Within this patient cohort, 16 developed AKI while 14 maintained normal renal function. The sequence of twenty peptides significantly associated with AKI was identified. They were found to be degradation products of six proteins. These formed a diagnostic pattern. Peptides of albumin, α-1-antitrypsin, and β-2-microglobulin were upregulated but fragments of fibrinogen α and collagens 1 α(I) and 1 α(III) were downregulated in AKI. After cross-validation of the training set, a good diagnostic performance of the marker pattern was found with an area under the ROC curve of 0.91. This was confirmed in a blinded validation set of 20 patients in the intensive care unit and 31 allogeneic hematopoietic stem cell transplantation patients, of which 13 had and 18 had not experienced an episode of AKI. In comparison to more established markers of AKI such as serum cystatin C and urinary kidney injury molecule-1, interleukin-18, and neutrophil gelatinase associated-lipocalin, the proteomic marker pattern was found to be of superior prognostic value, detecting AKI up to 5 days in advance of the rise in serum creatinine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20827258     DOI: 10.1038/ki.2010.322

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  37 in total

Review 1.  Proteomic biomarkers in kidney disease: issues in development and implementation.

Authors:  Harald Mischak; Christian Delles; Antonia Vlahou; Raymond Vanholder
Journal:  Nat Rev Nephrol       Date:  2015-02-03       Impact factor: 28.314

2.  Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS.

Authors:  Roxanne Cofiell; Anjli Kukreja; Krystin Bedard; Yan Yan; Angela P Mickle; Masayo Ogawa; Camille L Bedrosian; Susan J Faas
Journal:  Blood       Date:  2015-04-01       Impact factor: 22.113

Review 3.  Marking renal injury: can we move beyond serum creatinine?

Authors:  Jessica L Slocum; Michael Heung; Subramaniam Pennathur
Journal:  Transl Res       Date:  2012-02-03       Impact factor: 7.012

Review 4.  Developing proteomic biomarkers for bladder cancer: towards clinical application.

Authors:  Maria Frantzi; Agnieszka Latosinska; Leif Flühe; Marie C Hupe; Elena Critselis; Mario W Kramer; Axel S Merseburger; Harald Mischak; Antonia Vlahou
Journal:  Nat Rev Urol       Date:  2015-05-26       Impact factor: 14.432

Review 5.  Proteomic urinary biomarker approach in renal disease: from discovery to implementation.

Authors:  Joost P Schanstra; Harald Mischak
Journal:  Pediatr Nephrol       Date:  2014-03-15       Impact factor: 3.714

6.  A combined bile and urine proteomic test for cholangiocarcinoma diagnosis in patients with biliary strictures of unknown origin.

Authors:  Torsten Voigtländer; Jochen Metzger; Bastian Schönemeier; Mark Jäger; Harald Mischak; Michael P Manns; Tim O Lankisch
Journal:  United European Gastroenterol J       Date:  2017-01-11       Impact factor: 4.623

7.  Proteomic candidate biomarkers of drug-induced nephrotoxicity in the rat.

Authors:  Rodney Rouse; Justyna Siwy; William Mullen; Harald Mischak; Jochen Metzger; Joseph Hanig
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

Review 8.  Proteomics in acute kidney injury--current status and future promise.

Authors:  Julie Ho; Allison Dart; Claudio Rigatto
Journal:  Pediatr Nephrol       Date:  2013-04-18       Impact factor: 3.714

9.  Measurement of urinary cystatin C with a particle-enhanced turbidimetric immunoassay on Architect ci8200.

Authors:  Feria Hikmet Noraddin; Mats Flodin; Annika Fredricsson; Azita Sohrabian; Anders Larsson
Journal:  J Clin Lab Anal       Date:  2012-09       Impact factor: 2.352

10.  The association of albumin/creatinine ratio with postoperative AKI in children undergoing cardiac surgery.

Authors:  Michael Zappitelli; Steven G Coca; Amit X Garg; Catherine D Krawczeski; Philbrook Thiessen Heather; Kyaw Sint; Simon Li; Chirag R Parikh; Prasad Devarajan
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-23       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.